Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Longo

Showing results (61-70 of 484) with videos related to

Pageof 49
Sort By:
Journal of the National Cancer Institute|October 23, 1997
Aging and cancer: issues of basic and clinical scienceW B Ershler, D L Longo
Blood|July 1, 1992
Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapyR L Hornung, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 11, 1992
LymphomasD L Longo, V T DeVita
Cancer Treatment Reports|January 1, 1987
Media for LAK cell generationS K Beckner, D L Longo
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1990
T cell tumor cure by T cell receptor-mediated activation requires the development of CD8-dependent host immunityS H Bridges, D L Longo
Breast Cancer Research and Treatment|September 1, 1990
Biological response modifiers in the management of patients with breast cancerD L Longo, L C Hartmann
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
LymphomasL W Kwak, D L Longo
Important Advances in Oncology|January 1, 1995
Alteration of signal transduction in T cells from cancer patientsA C Ochoa, D L Longo
Current Opinion in Oncology|October 1, 1991
Treatment-related morbidity in patients with lymphomaS M Hubbard, D L Longo
Journal of the National Cancer Institute|February 19, 1997
Danger versus tolerance: paradigms for future studies of tumor-specific cytotoxic T lymphocytesR G Fenton, D L Longo
Pageof 49

Showing results (61-70 of 484) with videos related to

Sort By:
Pageof 49
Journal of the National Cancer Institute|October 23, 1997
Aging and cancer: issues of basic and clinical scienceW B Ershler, D L Longo
Blood|July 1, 1992
Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapyR L Hornung, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 11, 1992
LymphomasD L Longo, V T DeVita
Cancer Treatment Reports|January 1, 1987
Media for LAK cell generationS K Beckner, D L Longo
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1990
T cell tumor cure by T cell receptor-mediated activation requires the development of CD8-dependent host immunityS H Bridges, D L Longo
Breast Cancer Research and Treatment|September 1, 1990
Biological response modifiers in the management of patients with breast cancerD L Longo, L C Hartmann
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
LymphomasL W Kwak, D L Longo
Important Advances in Oncology|January 1, 1995
Alteration of signal transduction in T cells from cancer patientsA C Ochoa, D L Longo
Current Opinion in Oncology|October 1, 1991
Treatment-related morbidity in patients with lymphomaS M Hubbard, D L Longo
Journal of the National Cancer Institute|February 19, 1997
Danger versus tolerance: paradigms for future studies of tumor-specific cytotoxic T lymphocytesR G Fenton, D L Longo
Pageof 49